Amyloidosis Clinical Resources

com.bbi.amyloidosis_clinical_resources

View detailed information for Amyloidosis Clinical Resources — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
868(868)
Rating
0.0
Released
March 28, 2016
Last updated
July 21, 2020
Category
Medical
Developer
Börm Bruckmeier Publishing LLC
Developer details
Name
Börm Bruckmeier Publishing LLC
E-mail
bbpublishing.usa@gmail.com
Website
unknown
Country
United States
Address
Börm Bruckmeier Publishing LLC 111 1/2 Eucalyptus Dr. El Segundo, CA 90245 United States of America
Amyloidosis Clinical Resources Header - AppWisp.com

Screenshots

Amyloidosis Clinical Resources Screenshot 1 - AppWisp.com
Amyloidosis Clinical Resources Screenshot 2 - AppWisp.com
Amyloidosis Clinical Resources Screenshot 3 - AppWisp.com
Amyloidosis Clinical Resources Screenshot 4 - AppWisp.com

Description

Amyloidosis Diagnosis and Treatment App for healthcare professionals

A rare and challenging set of diseases including light chain (AL – kappa / lambda), transthyretin (hereditary, ATTR), secondary (AA) and wild-type (formerly called senile systemic), this app provides clinically relevant information that offers healthcare professionals a brief yet practical disease overview and interactive tools which can lead to earlier diagnosis and therapeutic intervention.

The content has been developed by Borm Bruckmeier Publishing in collaboration with the Amyloidosis Research Consortium and is intended for practicing physicians, resident physicians and other healthcare professionals involved in the diagnosis and treatment of patients with amyloidosis.

Highlights include:

• Descriptions of the most frequently seen types of amyloidosis
• Clinical presentations
• Signs and symptoms characteristic of amyloidosis
• Differential diagnoses
• Elements of the diagnostic workup including laboratory tests, biopsies, and genetic testing
• Treatment strategies including stem cell transplant, disease-modifying medications, clinical trials and novel agents
• Core treatment centers
• Clinical trials
• Comprehensive resources to share with patients including:
o Informative foundations and websites
o Support groups (USA and international)
o Treatment centers (USA and international)
o Educational webinars, disease pamphlets and guides
o Financial assistance for drugs and travel for treatment
o Caregiver resources